Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.700
+0.050 (1.37%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Company Description

Titan Pharmaceuticals, Inc. does not have significant operations.

Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals logo
Country United States
Founded 1991
IPO Date Jan 18, 1996
Industry Biotechnology
Sector Healthcare
Employees 4
CEO Weei Chay

Contact Details

Address:
10 East 53rd St., Suite 3001
New York, New York 10022
United States
Phone 650 244 4990
Website titanpharm.com

Stock Details

Ticker Symbol TTNP
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000910267
CUSIP Number 888314606
ISIN Number US8883147055
Employer ID 94-3171940
SIC Code 2836

Key Executives

Name Position
Jennifer Kiernan Executive Assistant to Chief Executive Officer and Investor Communications Coordinator
Weei Jye Chay Chief Executive Officer
Brynner Chiam Acting Principal Financial Officer and Director
Joe Schrei Executive Director of Commercial Operations

Latest SEC Filings

Date Type Title
Apr 22, 2025 8-K Current Report
Apr 22, 2025 PRE 14A Other preliminary proxy statements
Apr 1, 2025 8-K Current Report
Mar 20, 2025 10-K Annual Report
Jan 8, 2025 8-K Current Report
Jan 3, 2025 10-Q Quarterly Report
Dec 6, 2024 8-K Current Report
Nov 27, 2024 8-K Current Report
Nov 15, 2024 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Nov 8, 2024 8-K Current Report